Login
$LIPO
$0.00 +$0.00 (0.0%) Close

Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months
Officer Age In this role Joined 2023 pay Source
Jonathan Kaufman Also a director
Chief Executive Officer
58 Not stated Not stated $323,383

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 10-K annual report · updated by the 8-Ks of Oct 9, 2025, Oct 21, 2025, and Feb 4, 2026

Directors
4
serving now
Independent
3 of 4
stated in the proxy
Average tenure
7.2 years
from year joined
CEO also chairs the board
Yes
Jonathan Kaufman
Director Age On board Independent Committees Other public boards Pay Source
Jonathan Kaufman
58 2005
20 years
Not independent None stated None stated Paid as CEO
Daniel Cohen
60 2023
2 years
Independent None stated None stated Not stated
Byong (Christopher) Kim
54 2022
3 years
Independent None stated Bridge Biotherapeutics, Inc. Not stated
Ryan Pruchnic
50 2021
4 years
Independent
Audit Committee · Chair
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the 10-K annual report
Dr. Chancellor
co-founder
$100,000
August 2009 and January 2015

Promissory notes issued to co-founder, cancelled in connection with the IPO in exchange for 22,950 shares of Common Stock

With the Company Open in proxy
Jonathan Kaufman
Chief Executive Officer
$250,000
December 31, 2022

Cash contributed to the Company to support operations in the form of a note payable, paid in full at maturity

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support